{"id":12,"company":{"country":"IL","currency":"USD","exchange":"TEL AVIV STOCK EXCHANGE","ipo":"1951-01-01","marketCap":43299.3,"name":"Teva Pharmaceutical Industries Ltd","phone":"97239267267.0","outstanding":1120.87,"symbol":"TEVA","website":"https://www.tevapharm.com/","industry":"Pharmaceuticals"},"price":10.58,"year":2023,"month":9,"day":17,"weekday":"Sunday","title":"Historical Stock Splits and Corporate Actions of Teva Pharmaceutical Industries Ltd","date":"2023-09-17","url":"/posts/2023/09/17/TEVA","content":[{"section":"1991: Initial Public Offering (IPO)","text":"Teva Pharmaceutical Industries Ltd goes public with its Initial Public Offering."},{"section":"1993: First Stock Split","text":"Teva announces a 2-for-1 stock split, doubling the number of outstanding shares."},{"section":"1999: Acquisition of Sicor Inc.","text":"Teva acquires Sicor Inc., a global generic pharmaceuticals company, expanding its market presence."},{"section":"2000: Stock Split","text":"Teva announces a 3-for-1 stock split, increasing the number of outstanding shares."},{"section":"2002: Acquisition of AstraZeneca's Generic Drug Business","text":"Teva acquires AstraZeneca's generic drug business, further expanding its product portfolio."},{"section":"2006: Acquisition of Ivax Corporation","text":"Teva completes the acquisition of Ivax Corporation, enhancing its position as a leading generic pharmaceuticals company."},{"section":"2007: Stock Split","text":"Teva announces a 2-for-1 stock split, doubling the number of outstanding shares."},{"section":"2011: Acquisition of Cephalon Inc.","text":"Teva acquires Cephalon Inc., a biopharmaceutical company focused on specialty medicines."},{"section":"2015: Stock Split","text":"Teva announces a 2-for-1 stock split, doubling the number of outstanding shares."},{"section":"2016: Acquisition of Actavis Generics","text":"Teva completes the acquisition of Actavis Generics, significantly expanding its global reach in generic drugs."},{"section":"2017: Stock Split","text":"Teva announces a 2-for-1 stock split, doubling the number of outstanding shares."},{"section":"2018: Restructuring and Cost-Cutting Measures","text":"Teva implements a comprehensive restructuring plan to reduce costs and improve profitability."}],"tags":["stock","Long","Pharmaceuticals"],"news":[{"category":"company","date":1696069980,"headline":"Stocks are stuck in the breakdown lane and repairs will take time","id":122883494,"image":"","symbol":"TEVA","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3140169076"},{"category":"company","date":1695983580,"headline":"Biggest stock movers today: Walgreens Boots Alliance, Nike, Editas Medicine and more","id":122862383,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3138723052"},{"category":"company","date":1695978120,"headline":"Corcept Therapeutics plunges amid patent trial with Teva","id":122862386,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3138619514"},{"category":"company","date":1695952680,"headline":"Corcept Therapeutics plunges amid patent trial with Teva (update)","id":122885261,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3138965448"},{"category":"company","date":1695950880,"headline":"Corcept Therapeutics should be bought amid weakness, says Canaccord","id":122885262,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3138929637"},{"category":"company","date":1695931500,"headline":"Teva Announces Changes to Executive Management Team","id":122850510,"image":"https://media.zenfs.com/en/business-wire.com/aac6c577dbb8d60c4c02d1d0e8644445","symbol":"TEVA","publisher":"Yahoo","summary":"TEL AVIV, Israel \u0026 PARSIPPANY, N.J., September 28, 2023--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and Christine (Chris) Fox, who most recently served as Global President, Gene Therapies at Novartis will be the new head of Tevaâ€™s U.S. Commercial Business. \"On behalf of the Teva Board of Directors and our executive management team","url":"https://finance.yahoo.com/news/teva-announces-changes-executive-management-200500121.html"},{"category":"company","date":1695896220,"headline":"November 10th Options Now Available For Teva Pharmaceutical Industries (TEVA)","id":122847503,"image":"","symbol":"TEVA","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137020334"},{"category":"company","date":1695883680,"headline":"Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report (UPDATED)","id":122871140,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137740341"},{"category":"company","date":1695877740,"headline":"Market Today: Nike's Earnings Beat, Tesla Faces EEOC Lawsuit, and Novartis Executive Joins Teva","id":122847504,"image":"","symbol":"TEVA","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137588708"},{"category":"company","date":1695871980,"headline":"Teva names Novartis exec to lead US commercial business","id":122846356,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137447367"},{"category":"company","date":1695870420,"headline":"Teva announces EVP Sven Dethlefs to depart","id":122847506,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3137410497"},{"category":"company","date":1695804780,"headline":"Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories","id":122804894,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135151144"},{"category":"company","date":1695800880,"headline":"Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva","id":122847508,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135072560"},{"category":"company","date":1695790200,"headline":"Eli Lilly benefits as judge overturns $176.5M verdict in Teva patent case","id":122847509,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3135825627"},{"category":"company","date":1695760432,"headline":"US judge overturns Eli Lilly's $176.5 million loss in Teva patent case","id":122797033,"image":"https://media.zenfs.com/en/reuters-finance.com/0534d7644063ff8bffc0b7c67c4a186e","symbol":"TEVA","publisher":"Yahoo","summary":"Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly's migraine drug Emgality infringed three patents related to Teva's rival drug Ajovy.  U.S. District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing peptides were invalid.  \"The Court does not reach this decision nor overturn a jury verdict lightly,\" Burroughs said.","url":"https://finance.yahoo.com/news/us-judge-overturns-eli-lillys-203352787.html"},{"category":"company","date":1695722040,"headline":"Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report","id":122782965,"image":"","symbol":"TEVA","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3133538738"},{"category":"company","date":1695297300,"headline":"Teva put volume heavy and directionally bearish","id":122706864,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3127151394"},{"category":"company","date":1695295320,"headline":"November 3rd Options Now Available For Teva Pharmaceutical Industries","id":122706865,"image":"","symbol":"TEVA","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3127108456"},{"category":"company","date":1695274980,"headline":"Analystsâ€™ Top Healthcare Picks: Seelos Therapeutics (SEEL), Clene (CLNN)","id":122701664,"image":"","symbol":"TEVA","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3126726688"},{"category":"company","date":1695252867,"headline":"Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ...","id":122690734,"image":"https://media.zenfs.com/en/us.finance.gurufocus/cc15b7d28ff5129d33bebe03603f6c61","symbol":"TEVA","publisher":"Yahoo","summary":"Delving into the intrinsic value, financial strength, and growth prospects of Teva Pharmaceutical Industries","url":"https://finance.yahoo.com/news/unveiling-teva-pharmaceutical-industries-teva-233427213.html"},{"category":"company","date":1695190140,"headline":"Teva price target raised to $11 from $8 at UBS","id":122706867,"image":"","symbol":"TEVA","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3125099836"},{"category":"company","date":1695189480,"headline":"Alvotech Humira biosimilar accepted for FDA review","id":122686576,"image":"","symbol":"TEVA","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3125089127"}]}